Word: fda
(lookup in dictionary)
(lookup stats)
Dates: during 1990-1999
Sort By: most recent first
(reverse)
...authorities have had a hard time overseeing sites based outside their jurisdiction. While this isn't a new issue - states have been grappling with the problems posed by mail-order houses for years - the Web offers a new, more enticing arena for the sale of unregulated products. The new FDA commissioner, Dr. Jane Henney, told TIME Washington correspondent Dick Thompson that the agency's biggest concern is drug sales on the Web. "It seems like there's almost nothing they can do about it," Thompson says...
Recent legislation from the House Commerce Committee has called for the Food and Drug Administration (FDA) to label packages with a warning that condoms may not prevent the transmission...
...that occurred when it was mistaken for the seizure drug Cerebyx or the antidepressant Celexa. Searle, the maker of Celebrex, ran ads in medical journals this summer to point out the similarities to doctors and pharmacists and make them aware of the dangers of mixing them up. Although the FDA regulates drugs for safety and efficacy, it does not pay as close attention to their names...
Another new drug, called Remicade, approved just a few weeks ago by the FDA, is also the focus of a JAMA report. A medication called methotrexate has long been the treatment of choice for rheumatoid arthritis. It is not an NSAID, so it doesn't cause ulcers--but for many patients it stops working after a while. More than half the people who took Remicade along with methotrexate had at least a 20% reduction in arthritis symptoms, according to the study...
...drug that uses light rays to combat the severest form of the disease. Although their research couldn't help Levy's mother, who died in 1996, it has passed muster with a scientific advisory panel to the U.S. Food and Drug Administration. Last week the panel recommended that the FDA approve Visudyne as a treatment. If the agency agrees, the drug, which would be marketed by CIBA Vision, could be available in the U.S. early next year...